EarlySense (Waltham, Massachusetts), a company devoted to proactive patient care solutions, reported the results of a post regulatory approval clinical and non-interventional prospective study supporting the effectiveness of the EarlySense contact-free patient monitoring system to accurately predict patient deterioration.

Emerging and undeveloped markets are quickly becoming an inevitable reality for med-tech companies. As they begin to grow and med-tech firms' influence in these areas continues to increase, companies have been tasked with trying to get a better understanding of the new markets where innovation will be available.